Trials / Completed
CompletedNCT05365074
Intrathecal Chloroprocaine for Lower Limb Arthroplasty
Perioperative Outcomes in Patients Received Spinal Chloroprocaine for Hip or Knee Arthroplasty
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Hôpital de la Croix-Rousse · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This study evaluates the perioperative course in adult patients undergoing total or partial knee arthroplasty, or total hip arthroplasty under chloroprocaine spinal anesthesia.
Detailed description
This study evaluates the failure rate of spinal anesthesia, the duration of surgical anesthesia, the needs for complementary intraoperative analgesia, the time for recovery, the incidence of urinary retention, postoperative nausea and vomiting, and length of stay in the recovery room in patients operated for knee or hip arthroplasty under spinal anesthesia with chloroprocaine 50 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chloroprocaine Injection | Spinal anesthesia with 50 mg of 1% Chloroprocaine |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-12-31
- Completion
- 2022-03-02
- First posted
- 2022-05-09
- Last updated
- 2022-05-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05365074. Inclusion in this directory is not an endorsement.